Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

With advancements in the field of stem cell research accelerating, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions.

9 Oct 2009

MUSC enrolls first patient in the Stroke Treatment And Revascularization Therapy trial

The Stroke Team at the Medical University of South Carolina (MUSC) in Charleston, SC, including Aquilla Turk, DO, Associate Professor of Radiology, M. Imran Chaudry, MD, Assistant Professor of Radiology, and Raymond D. Turner IV, MD, Assistant Professor of Neurosurgery and Radiology, enrolled the first patient in the Stroke Treatment And Revascularization Therapy (START) trial.

8 Oct 2009

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Louis R. Caplan, MD, Senior Neurologist at Beth Israel Deaconess Medical Center (BIDMC) and a leader in the treatment and research of strokes, has been elected an Honorary Member of the American Neurological Association (ANA). As the organization's highest honor, Honorary Membership is reserved for select individuals who have made unique contributions to neurology and neurological science throughout their careers.

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

New results support rapid blood pressure treatment for patients with hemorrhagic stroke

New results support that treatment for hemorrhagic stroke can be improved by using medication to rapidly reduce blood pressure. Hemorrhagic stroke is a type of stroke that involves bleeding in the brain. About 35,000 patients a year in the United States have hemorrhagic stroke with corresponding high blood pressure.

8 Oct 2009

Reverse Medical Corporation commences human use of its ReStore Microcatheter

Reverse Medical Corporation announced today they have initiated human use of their ReStore™ Microcatheter for reestablishing blood flow in the Neurovasculature. The device was successfully used in an acute ischemic stroke patient in Germany.

8 Oct 2009

PP5 enzyme decrease in neurons can cause cell death in Alzheimer's disease patients

A Purdue University researcher has discovered that the amount of an enzyme present in neurons can affect the mechanism thought to cause cell death in Alzheimer's disease patients and may have applications for other diseases such as stroke and heart attack.

8 Oct 2009

New web-based tool to strengthen informed patient consent process launched

Krames, the leader in patient education, has announced the release of Krames Patient Consent, a comprehensive web-based tool designed to strengthen and streamline every aspect of the informed consent process.

8 Oct 2009

New study to assess the risk of heart disease in diabetics

In a new international partnership, Dr. Randy Nelson, a researcher at Arizona State University's Biodesign Institute, and Dr. Tai E-Shyong , associate professor at Singapore's National University Hospital, National University Health System (NUHS), have teamed up to assess the risk of heart disease in diabetics with greater accuracy.

8 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

Research and development using stem cells from menstrual blood helps fight against breast cancer

Cryo-Cell International, a global leader in stem cell innovation, is proud to be making progress in the fight against breast cancer through research and development using stem cells from menstrual blood.

7 Oct 2009

Award-winning GWTG hospitals have lower mortality rates for heart attack and heart failure patients: Study

Hospitals receiving performance awards from the American Heart Association's Get With The Guidelines (GWTG) quality improvement initiative have lower mortality rates for heart attack and heart failure patients than all other hospitals, according to a new study.

7 Oct 2009

Diuretics effective as second-line agents in treating high blood pressure

A new review shows that diuretics — drugs often recommended as a first-line treatment for high blood pressure — are also effective when added as a second agent to other blood-pressure lowering drugs.

7 Oct 2009

HRT may increase urinary incontinence in postmenopausal women

Grappling with the risks and benefits of hormone replacement therapy (HRT) is nothing new for postmenopausal women. Researchers have now added more fuel to the fire, with evidence that HRT could play a role in incontinence.

7 Oct 2009

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Data results published this month in Clinical Neuropharmacology, revealed that Merz Pharmaceuticals' NT 201 (botulinum toxin type A free from complexing proteins), also known by the brand name Xeomin in Europe and Canada, was statistically significantly more efficacious than placebo for the treatment of patients with post-stroke upper limb spasticity.

7 Oct 2009

Stroke News and Research

Further Reading

NHLBI to hold Symposium to review latest findings in Cardiovascular Regenerative Medicine

MUSC enrolls first patient in the Stroke Treatment And Revascularization Therapy trial

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

New results support rapid blood pressure treatment for patients with hemorrhagic stroke

Reverse Medical Corporation commences human use of its ReStore Microcatheter

PP5 enzyme decrease in neurons can cause cell death in Alzheimer's disease patients

New web-based tool to strengthen informed patient consent process launched

New study to assess the risk of heart disease in diabetics

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Research to explore diagnosis and treatment of rare diseases

Research and development using stem cells from menstrual blood helps fight against breast cancer

Award-winning GWTG hospitals have lower mortality rates for heart attack and heart failure patients: Study

Diuretics effective as second-line agents in treating high blood pressure

HRT may increase urinary incontinence in postmenopausal women

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

B-vitamin supplements do not prevent heart attack

Cardiorespiratory training can improve walking in stroke patients

CE Mark approval for AtriClip System

U.S. lags behind industrialized countries on preventable deaths

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News